Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

PROX1 is a predictor of survival for gliomas WHO grade II.

British journal of cancer - 24 May 2011

Elsir T, Qu M, Berntsson S G, Orrego A, Olofsson T, Lindström M S, Nistér M, von Deimling A, Hartmann C, Ribom D, Smits A

Abstract excerpt

BACKGROUND: The clinical course of World Health Organisation grade II gliomas remains variable and their time point of transformation into a more malignant phenotype is unpredictable. Identification of biological markers that can predict prognosis in individual patients is of great clinical value. PROX1 is a transcription factor that has a critical role in the development of various organs. PROX1 has been...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Brain Neoplasms
Share to Glioma

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Homeodomain Proteins

Share to Isocitrate Dehydrogenase

Share to Loss of Heterozygosity

Share to Survival Analysis

Share to Tumor Suppressor Proteins

Source

Open in PubMed Open full text

Identifiers

PMID: 21559010
DOI: 10.1038/bjc.2011.162
PMCID: PMC3111172

Genes

PROX1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

PROX1 is a predictor of survival for gliomas WHO grade II.PMID 21559010Read ↗

PROX1 is a novel pathway-specific prognostic biomarker for high-grade astrocytomas; results from independent glioblastoma cohorts stratified by age and IDH mutation status.Semantic proximity Read ↗

Histopathological grading affects survival in patients with IDH-mutant grade II and grade III diffuse gliomas.Semantic proximity Read ↗

Olig2 labeling index is correlated with histological and molecular classifications in low-grade diffuse gliomas.Semantic proximity Read ↗

Diagnostic and prognostic value of alpha internexin expression in a series of 409 gliomas.Semantic proximity Read ↗

IRX1 is a novel gene, overexpressed in high-grade IDH-mutant astrocytomas.Semantic proximity Read ↗

Molecular markers in low-grade gliomas: predictive or prognostic?Semantic proximity Read ↗

Sox11 expression in astrocytic gliomas: correlation with nestin/c-Met/IDH1-R132H expression phenotypes, p-Stat-3 and survival.Semantic proximity Read ↗

Low FoxG1 and high Olig-2 labelling indices define a prognostically favourable subset in isocitrate dehydrogenase (IDH)-mutant gliomas.Semantic proximity Read ↗

Diagnostic Value of Nestin Expression in Adult Gliomas.Semantic proximity Read ↗

Oligodendrocyte lineage genes ( <i>OLIG</i> ) as molecular markers for human glial brain tumorsSemantic proximity Read ↗

Expression of Olig2, Nestin, NogoA and AQP4 have no impact on overall survival in IDH-wildtype glioblastoma.Semantic proximity Read ↗

A Homeobox Protein, Prox1, Is Involved in the Differentiation, Proliferation, and Prognosis in Hepatocellular CarcinomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.